已收盘 12-19 16:00:00 美东时间
-0.810
-2.05%
PRLD: 70% | Prelude Therapeutics Signs Agreement For Incyte To Acquire JAK2V617F JH2 Inhibitor Program In Development For Patients With Myeloproliferative Neoplasms NSP: -32% | Insperity shares are trading
11-04 20:24
Insperity (NYSE:NSP) is looking for Q4 Adj EPS of $(0.79)-$(0.16) vs $0.08 analyst estimate..
11-04 05:59
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
11-03 19:11
原标题:现象级大药机会,被引爆 我们不止一次提到过呼吸疾病赛道的巨大机会,包括《一个超级大药机会,将被引爆》、《下一个现象级大药蓄势》、《一哥超预期,引爆重磅...
08-14 07:54
Nature’s Sunshine Products partners with the University of Utah’s David Eccles School of Business to renew its scholarship program, committing $200,000 over four years to support underprivileged students, particularly first-generation college students, fostering community inclusivity and empowering the disadvantaged.
06-09 15:00
InspireMD appoints Michael Lawless as CFO, replacing Craig Shore after nearly 15 years, to lead the company's growth phase, including the U.S. launch of CGuard Prime. Lawless brings extensive healthcare financial leadership experience. As part of the inducement compensation, he will receive restricted stock and stock options vesting over three years.
06-03 20:05
Inspire Medical Systems will present at the Wells Fargo 2025 MedTech Innovation Spotlight on June 13, 2025, at 12:00 p.m. ET. The presentation will be available via live webcast and replay for two weeks afterward.
05-30 12:00
U.S. stocks were lower, with the Nasdaq Composite falling around 650 points on ...
03-11 00:15
William Blair analyst Andrew Nicholas downgrades Insperity (NYSE:NSP) from Outperform to Market Perform.
2024-09-24 21:32
05:17 PM EDT, 08/27/2024 (MT Newswires) -- Insperity (NSP) said late Tuesday that it has appointed James Allison as chief financial officer, succeeding Douglas Sharp, who will retire. Both changes are effective Nov. 15, the company said. Allison currently serves as executive vice president of compre...
2024-08-28 05:17